2. Cheong S.J., Yoon J.L., Choi S.H., Kim M.Y., Cho J.J., Ju Y.S.. The effect of polypharmacy on mortality in the elderly. Korean Journal of Family Practice. 2016;6(6):643-650.
https://doi.org/10.21215/kjfp.2016.6.6.643
3. Korean Society for Pharmacoepidemiology and Risk Management. Pharmacodynamics. 2012 Seoul: Seoul National University Publishing & Cultural Center.
4. Park H.Y., Sohn H.S., Kwon J.W.. Reviews on the current status and appropriate management of polypharmacy in South Korea. Korean Journal of Clinical Pharmacy. 2018;28(1):1-9.
https://doi.org/10.24304/kjcp.2018.28.1.1
5. Onder G., Liperoti R., Fialova D., Topinkova E., Tosato M., Danese P., et al. Polypharmacy in nursing home in Europe: results from the SHELTER study. Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences. 2012;67(6):698-704.
https://doi.org/10.1093/gerona/glr233
6. Charlesworth C.J., Smit E., Lee D.S., Alramadhan F., Odden M.C.. Polypharmacy among adults aged 65 years and older in the United States: 1988-2010. Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences. 2015;70(8):989-995.
https://doi.org/10.1093/gerona/glv013
7. Bhagavathula A.S., Gebreyohannes E.A., Fialova D.. Prevalence of polypharmacy and risks of potentially inappropriate medication use in the older population in a developing country: a systematic review and meta-analysis. Gerontology. 2022;68:136-145.
https://doi.org/10.1159/000516075
8. By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society. 2015;63(11):2227-2246.
https://doi.org/10.1111/jgs.13702
13. Freeland K.N., Thompson A.N., Zhao Y., Leal J.E., Mauldin P.D., Moran W.P.. Medication use and associated risk of falling in a geriatric outpatient population. Annals of Pharmacotherapy. 2012;46(9):1188-1192.
https://doi.org/10.1345/aph.1Q689
14. Kojima T., Akishita M., Nakamura T., Nomura K., Ogawa S., Iijima K., et al. Association of polypharmacy with fall risk among geriatric outpatients. Geriatrics & Gerontology International. 2011;11(4):438-444.
https://doi.org/10.1111/j.1447-0594.2011.00703.x
17. Seo D.S., Yoon J.L., Kim S.J., Park J.S., Lee W.J., Kim M.Y.. Polypharmacy in older patients admitted to a general hospital. Journal of the Korean Geriatrics Society. 2012;16(3):133-140.
https://doi.org/10.4235/jkgs.2012.16.3.133
18. Bennett A., Gnjidic D., Gillett M., Carroll P., Matthews S., Johnell K., et al. Prevalence and impact of fall-risk-increasing drugs, polypharmacy, and drug-drug interactions in robust versus frail hospitalised falls patients: a prospective cohort study. Drugs & Aging. 2014;31(3):225-232.
https://doi.org/10.1007/s40266-013-0151-3
19. Lim J.O., Gu M.O.. Fall-related circumstances and fall risk factors among inpatients with dementia in long-term care hospital. Journal of Korean Gerontologcial Nursing. 2016;18(2):72-83.
https://doi.org/10.17079/jkgn.2016.18.2.72
20. Lai S.W., Liao K.F., Liao C.C., Muo C.H., Liu C.S., Sung F.C.. Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine. 2010;89(5):295-299.
https://doi.org/10.1097/MD.0b013e3181f15efc
21. Ziere G., Dieleman J.P., Hofman A., Pols H.A.P., van der Cammen T.J.M., Stricker B.H.. Polypharmacy and falls in the middle age and elderly population. British Journal of Clinical Pharmacology. 2006;61(2):218-223.
https://doi.org/10.1111/j.1365-2125.2005.02543.x
22. Lee J.K.. Factors associated with drug misuse behaviors among polypharmacy elderly. Korean Journal of Adult Nursing. 2011;23(6):554-563.
23. Lee Y.J.. Medication use as a risk factor for falls in hospitalized elderly patients in Korea. Korean Journal of Clinical Pharmacy. 2011;21(3):243-248.
24. Park Y.I., Lee K.Y., Kim D.O., Uhm D.C., Kim J.H.. Medication status and the effects of a medication management education program for the elderly in a community. Journal of Korean Academy of Community Health Nursing. 2014;25(3):170-179.
https://doi.org/10.12799/jkachn.2014.25.3.170
25. Huang A.R., Mallet L., Rochefort C.M., Eguale T., Buckeridge D.L., Tamblyn R.. Medication-related falls in the elderly: causative factors and preventive strategies. Drugs & Aging. 2012;29(5):359-376.
https://doi.org/10.2165/11599460-000000000-00000
26. Fraser L-A., Leslie W.D., Targownik L.E., Papaioannou A., Adachi J.D.. The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study. Osteoporosis International. 2013;24(4):1161-1168.
https://doi.org/10.1007/s00198-012-2112-9
28. Park J.Y., Jun K., Baek Y.S., Park S.Y., Lee J-Y.. Medication use review tools for community dwelling older patients: a systematic review. Korean Journal of Clinical Pharmacy. 2021;31(1):61-78.
https://doi.org/10.24304/kjcp.2021.31.1.61
29. Park H.Y., Ryu H.N., Shim M.K., Sohn H.S., Kwon J.W.. Prescribed drugs and polypharmacy in healthcare service users in South Korea: an analysis based on National Health Insurance Claims data. International Journal of Clinical Pharmacology and Therapeutics. 2016;54(5):369-377.
https://doi.org/10.5414/CP202484
30. Bae M.K., Lee I.H., Yoon J.H.. Assessment of potentially inappropriate medication use in Korean elderly patients with chronic heart failure. Korean Journal of Clinical Pharmacy. 2014;24(2):115-125.
32. Levy H.B.. Polypharmacy reduction strategies: tips on incorporating American Geriatrics Society Beers and Screening Tool of Older People’s Prescriptions Criteria. Clinics in Geriatric Medicine. 2017;33(2):177-187.
https://doi.org/10.1016/j.cger.2017.01.007